CD274 and neoplasm: We lastly examined the pan-solid tumor distribution of IRS groups by TMB status, given the pan-tumor approval of pembrolizumab in TMB-H tumors and prospective trials showing efficacy of other PD-(L)1 monotherapies patients with TMB-H.